8-K filed Jul 1, 2026 at 09:27 ET
Select Medical Holdings Corporation (SEM) was acquired by a consortium led by Robert A. Ortenzio, Martin F. Jackson, and Welsh, Carson, Anderson & Stowe (WCAS) in a take-private transaction that closed on June 30, 2026. Shareholders received $16.50 per share in cash, representing an ~18% premium to the unaffected price. The company simultaneously entered into a $1 billion incremental term loan facility to help finance the acquisition. As a result, SEM common stock is being delisted from the NYSE and will be deregistered, with the company becoming a wholly-owned indirect subsidiary of the acquirer.